In chronic myeloid leukemia (CML), the BCR-ABL1 fusion protein of the p210 isoform constitutively activates which downstream signaling pathway primarily responsible for anti-apoptotic survival?
- A NOTCH pathway
- B Hedgehog-GLI pathway
- C PI3K-AKT-mTOR pathway ✓
- D TGF-beta-SMAD pathway
Explanation
The BCR-ABL1 kinase in CML constitutively activates multiple downstream signaling cascades, but PI3K-AKT-mTOR is the primary pathway mediating anti-apoptotic survival signals by phosphorylating and inactivating pro-apoptotic factors such as BAD. RAS-MAPK (proliferation) and JAK-STAT (survival and differentiation) are also activated. The NOTCH, Hedgehog, and TGF-beta pathways are not direct downstream targets of BCR-ABL1.
Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.